It was reported that triple-negative breast cancer cells (MDA-MB-468) can produce exosomes with encapsulated EGFR (protected from EGFR inhibitor), which can induce EGFR signaling in target cells, thereby promoting cancer progression or resistance to therapy (99). This evidence concerns the gene EGFR and cancer.